Ambuja Cements Q1 FY27 Results & Concall Highlights: Revenue, Margins & Order Book

Q1 FY27 earnings call analysis: revenue, margin, capex, fundraise and order book outlook from management commentary.

Published 25 Aug 2026 | Cement & Cement Products | Market Cap: ₹1.0L Cr

Ambuja Cements targets an 8% volume growth for FY27, driven primarily by trade sales, which constitute over 75% of total sales. Ambuja Cements targets an 8% volume growth for FY27, supported by trade volume growth of about 8% seen in July post-Q1 decline.

From Ambuja Cements's Q1 FY27 earnings-call transcript · updated 25 Aug 2026.

Price

410

Market Cap

₹1.0L Cr

P/E Ratio

21.9

How does Ambuja Cements rank in Cement & Cement Products?

Compare Ambuja Cements against every Cement & Cement Products company this quarter on revenue, margins and earnings-call signals.

Revenue: Rank 4Margin: Rank 3
View Cement & Cement Products leaderboard →

Ambuja Cements — Quarterly revenue & net profit

Revenue Net Profit
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹10.9K Cr, net profit ₹1.9K Cr.

Full financials →

📊 Revenue & Sales Performance

Rank 4
  • Ambuja Cements targets an 8% volume growth for FY27, driven primarily by trade sales, which constitute over 75% of total sales.
  • In July (post-Q1), they reported an 8% year-on-year growth in trade volumes, indicating a positive recovery after a decline in Q1.
  • The focus remains on growing high-margin trade segments and expanding brand equity in key markets, supported by investments in channel development.
  • New capacity additions of about 10.2 million tons by FY27 are expected to bolster volume growth.
  • They aim to maintain disciplined execution, premiumization, operational excellence, and digital transformation to sustain revenue growth.
  • The mix shift towards value sales (trade) is expected to improve revenue per ton, balancing volume growth with profitability.
  • Long-term demand fundamentals in India remain strong due to infrastructure, urbanization, and housing demand.

See what Ambuja Cements said on profitability & margins — free account, 30 seconds.

🏗️ Capital Expenditure Plans

Yes
  • Capex for FY27 is around INR 6,500 crores, covering growth and efficiency projects.
  • Capacity expected to reach 119 million tons by end of FY27.
  • Organic capacity additions planned for FY28 and FY29, with 8-10 million tons added annually.
  • Expansion in North India completed, adding almost 5.5 million tons capacity.
  • West region expansion underway, including Kalamboli adding 1 million tons.
  • Additional expansions in Bihar, East, and Central regions ongoing.
  • Temporary suspension (not mothballing) of some old ACC and acquired company plants for optimization before restarting.
  • Investments in rail infrastructure (BCFC), fly ash sourcing, waste heat recovery system (WHRS), and renewable energy.
  • Focus on cost optimization through technical efficiency, logistics improvements, and RE power.

See what Ambuja Cements said on fundraising & capital structure — free account, 30 seconds.

📋 Order Book & Pipeline

No information
The provided transcript from Ambuja Cements Limited's July 28, 2026 call does not explicitly mention current or expected order book or pending orders details. However, some relevant insights include: - The company is targeting approximately 8% volume growth for FY27. - Strong momentum and demand traction are seen in key markets like North, West, Central, and East. - In July, an 8% year-on-year improvement in trade volumes was reported, indicating growing demand. - Several capacity expansions are underway or planned (e.g., clinker capacities at Jodhpur commissioned, Maratha expected FY28). - Temporary mothballing of older manufacturing facilities is for optimization, not loss of market share. - The focus is on value-driven volume growth with premiumization and operational efficiency. No direct figures or specifics related to order book or pending orders are provided in the excerpts.

Key Metrics

1 of 5 growth signals positive in the Q1 FY27 call.

Revenue

Rank 4

Margin

Rank 3

Capex

Yes

Fundraise

No information

Order Book

No information

How does Ambuja Cements rank vs peers in Cement & Cement Products?

Pro feature
1Ambuja Cements
Rev 4Mar 3

See full Cement & Cement Products sector rankings

Others in Cement & Cement Products this season

  • JSWCEMENT (Q1 FY27)

    Excluding North, cement volume growth was 8% in Q1. Key concall takeaways from JSW Cement Ltd's Q1 FY27 earnings call — and how it ranks against sector peers.

  • ORIENTCEM (Q1 FY27)

    July saw an 8% year-on-year growth in trade volumes, indicating a positive momentum after prior disruptions. Key concall takeaways from Orient Cement's Q1 FY27…

  • JKCEMENT (Q1 FY27)

    Capex plans include INR3500 crores for FY27 and around INR1200 crores for FY28, with potential additional expansions. Key concall takeaways from J K Cements's…

  • Nuvoco Vistas Corporation Ltd (Q1 FY27)

    Capex of INR 900 crore for FY27 (with INR 370 crore spent in Q1) supports capacity expansions and operational improvements. Key concall takeaways from Nuvoco…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were Ambuja Cements Q1 FY27 results?

Ambuja Cements targets an 8% volume growth for FY27, driven primarily by trade sales, which constitute over 75% of total sales. Ambuja Cements targets an 8% volume growth for FY27, supported by trade volume growth of about 8% seen in July post-Q1 decline.

What is Ambuja Cements share price analysis?

Ambuja Cements currently shows a neutral. The stock trades at a P/E of 21.9 with a market cap of ₹102,996 Cr. Investors should review the full earnings analysis for detailed insights.

Is Ambuja Cements planning capital expenditure?

Capex for FY27 is around INR 6,500 crores, covering growth and efficiency projects.

Keep Ambuja Cements on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.